Showing results (31-40 of 144) with videos related to
Sort By:
Pageof 15
Journal of Clinical Pathology|July 2, 2013
Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkersDouglas W Henderson, Glen Reid, Steven C Kao, et al.International Forum of Allergy & Rhinology|September 23, 2014
Aquaporin expression profiles in normal sinonasal mucosa and chronic rhinosinusitisClaire Frauenfelder, Charmaine Woods, Damian Hussey, et al.Asia-Pacific Journal of Clinical Oncology|November 22, 2012
Immunohistochemistry in the diagnosis of malignant pleural mesothelioma: trends in Australia and a literature reviewAnthony Linton, Steven Kao, Janette Vardy, et al.Disease Markers|March 31, 2015
Blockade of aquaporin 1 inhibits proliferation, motility, and metastatic potential of mesothelioma in vitro but not in an in vivo modelSonja Klebe, Kim Griggs, Yuen Cheng, et al.Journal of Clinical Pathology|July 9, 2013
Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNADouglas W Henderson, Glen Reid, Steven C Kao, et al.Case Reports in Genetics|September 23, 2022
BAP1 Tumour Predisposition Syndrome Due to Whole BAP1 Gene DeletionDinusha Pandithan, Sonja Klebe, Grace McKavanagh, et al.Radiation Research|May 17, 2019
DMAPT is an Effective Radioprotector from Long-Term Radiation-Induced Damage to Normal Mouse Tissues In VivoKatherine L Morel, Rebecca J Ormsby, Sonja Klebe, et al.Biomarker Research|July 4, 2015
BAP1 hereditary cancer predisposition syndrome: a case report and review of literatureSonja Klebe, Jack Driml, Masaki Nasu, et al.Pathology|March 26, 2011
Molecular biomarkers in malignant mesothelioma: state of the artSteven Chuan-Hao Kao, Glen Reid, Nico van Zandwijk, et al.Molecular Genetics and Metabolism|August 8, 2007
Improvement in behaviour after substrate deprivation therapy with rhodamine B in a mouse model of MPS IIIAAinslie L K Roberts, Matthew H Rees, Sonja Klebe, et al.Pageof 15